2018
DOI: 10.1002/jpen.1447
|View full text |Cite
|
Sign up to set email alerts
|

Dietary Management of Blood Glucose in Medical Critically Ill Overweight and Obese Patients: An Open‐Label Randomized Trial

Abstract: Background: Enteral nutrition (EN) increases hyperglycemia due to high carbohydrate concentrations while providing insufficient protein. The study tested whether an EN formula with very high‐protein‐ and low‐carbohydrate‐facilitated glucose control delivered higher protein concentrations within a hypocaloric protocol. Methods: This was a multicenter, randomized, open‐label clinical trial with parallel design in overweight/obese mechanically ventilated critically ill patients prescribed 1.5 g protein/kg ideal b… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
26
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 20 publications
(28 citation statements)
references
References 38 publications
(70 reference statements)
2
26
0
Order By: Relevance
“…Historically, critical care nutrition literature has focused on energy delivery in critical illness based on the assumption that carbohydrates inhibit protein catabolism, which could decrease the loss of muscle 22,26 . In critical illness however, benefit has not been shown from meeting caloric goals and may be associated with significant side effects, including hyperglycemia 26,27 .…”
Section: Introductionmentioning
confidence: 99%
“…Historically, critical care nutrition literature has focused on energy delivery in critical illness based on the assumption that carbohydrates inhibit protein catabolism, which could decrease the loss of muscle 22,26 . In critical illness however, benefit has not been shown from meeting caloric goals and may be associated with significant side effects, including hyperglycemia 26,27 .…”
Section: Introductionmentioning
confidence: 99%
“…Since C‐reactive protein levels were measured, the authors could assess the level of stress in this group to confirm its mild degree on average. These findings in the present study raise the question of the potential role, if any, for the application of full ketogenic diets in the critically ill because of the seemingly good tolerance of the experimental diet. Recent evidence with ketogenic diets with more extreme carbohydrate limitation and providing energy balance has demonstrated improved glucose control and potential anti‐inflammatory effects in studies in animals .…”
mentioning
confidence: 64%
“…The higher protein but lower carbohydrate with similar energy content in the experimental compared with the control diet when fed to provide similar amounts of protein intake led to substantially lower carbohydrate (88 vs 192 g/d) intake with similar amounts of fat (45 vs 57 g/d) in this modest sized study. A “small statistically significant increase in urinary ketones” was noted with the experimental diet, and serum ketones, although not significantly higher at 0.26, could mean at maximum that one‐half of the experimental group had trace ketonemia. This is not totally unexpected, given that 100 g glucose/d is generally thought to be sufficient to eliminate significant ketonemia and ketonuria in man and that 50 g daily or less as carbohydrate is generally the goal for mildly hypocaloric or eucaloric ketogenic diets used clinically to treat epilepsy and more recently type 2 diabetes in the obese .…”
mentioning
confidence: 91%
See 1 more Smart Citation
“…In surgical populations, a meta-analysis of immunonutrition that evaluated preoperative, perioperative, and postoperative uses of arginine-supplemented diets showed a 41% reduction in infectious complications (the primary outcome) and a reduction in length of stay of 2.38 d ( 76 ). Finally, in critically ill patients with obesity in the ICU, hypocaloric high-protein and low-carbohydrate enteral nutrition has been shown to improve glucose management ( 77 ).…”
Section: New Types Of Evidence and Product Innovationmentioning
confidence: 99%